News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
365,946 Results
Type
Article (22705)
Company Profile (31)
Press Release (343210)
Multimedia
Podcasts (77)
Webinars (6)
Section
Business (120138)
Career Advice (1398)
Deals (18144)
Drug Delivery (54)
Drug Development (42115)
Employer Resources (94)
FDA (8634)
Job Trends (8428)
News (191833)
Policy (17268)
Tag
2024 BioCapital Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (3)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1466)
Academic (1)
Accelerated approval (4)
Adcomms (10)
Allergies (49)
Alliances (33216)
ALS (55)
Alzheimer's disease (834)
Antibody-drug conjugate (ADC) (68)
Approvals (8670)
Artificial intelligence (163)
Autoimmune disease (13)
Automation (13)
Bankruptcy (180)
Best Places to Work (7063)
BIOSECURE Act (6)
Biosimilars (51)
Biotechnology (25)
Bladder cancer (56)
Brain cancer (11)
Breast cancer (179)
Cancer (1420)
Cardiovascular disease (110)
Career advice (1187)
Career pathing (23)
CAR-T (79)
Cell therapy (269)
Cervical cancer (13)
Clinical research (34225)
Collaboration (614)
Compensation (118)
Complete response letters (8)
COVID-19 (1414)
CRISPR (25)
C-suite (116)
Cystic fibrosis (52)
Data (1464)
Decentralized trials (2)
Denatured (26)
Depression (22)
Diabetes (183)
Diagnostics (3418)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (29)
Drug discovery (74)
Drug pricing (55)
Drug shortages (18)
Duchenne muscular dystrophy (64)
Earnings (55117)
Editorial (29)
Employer branding (12)
Employer resources (82)
Events (54718)
Executive appointments (402)
FDA (9377)
Featured Employer (16)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (414)
Gene editing (58)
Generative AI (18)
Gene therapy (209)
GLP-1 (415)
Government (2243)
Grass and pollen (4)
Guidances (42)
Healthcare (10266)
Huntington's disease (12)
IgA nephropathy (17)
Immunology and inflammation (71)
Indications (22)
Infectious disease (1488)
Inflammatory bowel disease (88)
Inflation Reduction Act (8)
Influenza (27)
Intellectual property (62)
Interviews (260)
IPO (8487)
IRA (26)
Job creations (1717)
Job search strategy (987)
Kidney cancer (4)
Labor market (21)
Layoffs (211)
Leadership (14)
Legal (4624)
Liver cancer (34)
Lung cancer (212)
Lymphoma (95)
Machine learning (2)
Management (32)
Manufacturing (178)
MASH (46)
Medical device (6673)
Medtech (6677)
Mergers & acquisitions (10037)
Metabolic disorders (436)
Multiple sclerosis (51)
NASH (9)
Neurodegenerative disease (50)
Neuropsychiatric disorders (14)
Neuroscience (1142)
NextGen: Class of 2025 (3421)
Non-profit (2715)
Northern California (1512)
Now hiring (5)
Obesity (217)
Opinion (153)
Ovarian cancer (42)
Pain (50)
Pancreatic cancer (47)
Parkinson's disease (82)
Partnered (12)
Patents (139)
Patient recruitment (62)
Peanut (23)
People (28173)
Pharmaceutical (9)
Pharmacy benefit managers (8)
Phase I (10221)
Phase II (14541)
Phase III (12201)
Pipeline (907)
Policy (85)
Postmarket research (1637)
Preclinical (4527)
Press Release (33)
Prostate cancer (91)
Psychedelics (19)
Radiopharmaceuticals (150)
Rare diseases (230)
Real estate (2549)
Recruiting (36)
Regulatory (11581)
Reports (16)
Research institute (1342)
Resumes & cover letters (214)
Rett syndrome (1)
RNA editing (3)
RSV (23)
Schizophrenia (42)
Series A (73)
Series B (38)
Service/supplier (3)
Sickle cell disease (36)
Southern California (1309)
Special edition (7)
Spinal muscular atrophy (68)
Sponsored (17)
Startups (1552)
State (1)
Stomach cancer (9)
Supply chain (33)
Tariffs (21)
The Weekly (50)
United States (13403)
Vaccines (391)
Venture capitalists (19)
Weight loss (133)
Women's health (18)
Worklife (11)
Date
Today (113)
Last 7 days (484)
Last 30 days (1569)
Last 365 days (19487)
2025 (6359)
2024 (20381)
2023 (22412)
2022 (28232)
2021 (30232)
2020 (29441)
2019 (25547)
2018 (18812)
2017 (17709)
2016 (17206)
2015 (19592)
2014 (16450)
2013 (14433)
2012 (14234)
2011 (13721)
2010 (12847)
Location
Africa (534)
Alabama (44)
Alaska (5)
Arizona (85)
Arkansas (7)
Asia (21142)
Australia (3467)
California (3413)
Canada (1186)
China (302)
Colorado (173)
Connecticut (181)
Delaware (88)
Europe (49923)
Florida (599)
Georgia (136)
Idaho (21)
Illinois (298)
India (19)
Indiana (201)
Iowa (4)
Japan (108)
Kansas (55)
Kentucky (8)
Louisiana (4)
Maine (27)
Maryland (485)
Massachusetts (2630)
Michigan (124)
Minnesota (175)
Missouri (33)
Montana (8)
Nebraska (9)
Nevada (34)
New Hampshire (32)
New Jersey (1149)
New Mexico (12)
New York (1053)
North Carolina (608)
North Dakota (3)
Northern California (1512)
Ohio (104)
Oklahoma (11)
Oregon (19)
Pennsylvania (809)
Puerto Rico (1)
Rhode Island (20)
South America (744)
South Carolina (14)
Southern California (1309)
Tennessee (69)
Texas (502)
Utah (118)
Virginia (76)
Washington D.C. (40)
Washington State (323)
West Virginia (2)
Wisconsin (27)
365,946 Results for "venable baetjer and howard llp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Hoth Therapeutics, Inc. today announced that it will continue its work with Venable, LLP to develop and protect its intellectual property.
February 29, 2024
·
4 min read
Press Releases
Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program
April 17, 2025
·
7 min read
Press Releases
STX PARTNERS LLP and Newlin Investment Co. Exercise Warrants of Sharp Therapeutics Corp.
April 21, 2025
·
3 min read
Press Releases
Walden Biosciences Appoints Howard Mayer, M.D. to Board of Directors
January 28, 2025
·
3 min read
Press Releases
ME Therapeutics Announces It Has Engaged Lucosky Brookman LLP to Explore a Listing on the NASDAQ or NYSE
March 3, 2025
·
4 min read
Press Releases
Sunflower Therapeutics Engages PharmNXT Biotech LLP as Distributor for the Daisy Petal™ Perfusion Bioreactor System
February 26, 2025
·
3 min read
Press Releases
Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer
November 13, 2024
·
2 min read
Press Releases
Bleichmar Fonti & Auld LLP Announces a Proposed Settlement in the In re Talis Biomedical Corporation Securities Litigation
December 23, 2024
·
4 min read
Business
Coya Therapeutics’ CEO Dr. Howard Berman’s Letter to Stockholders - December 13, 2023
Coya Therapeutics, Inc. today released the following letter to stockholders from its Chief Executive Officer and Chairman, Dr. Howard Berman.
December 13, 2023
·
10 min read
Business
PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors
PepGen Inc. today announced the appointment of Howard Mayer, M.D. to the PepGen Board of Directors, effective November 15, 2023.
November 15, 2023
·
4 min read
1 of 36,595
Next
